Baker Bros. Advisors LP 13D and 13G filings for Aeglea BioTherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | Baker Bros. Advisors LP | 255,361 9.900% | 53,582 (+26.55%) | Filing |
| 2022-02-10 5:03 pm Purchase | 2022-02-09 | 13D | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | Baker Bros. Advisors LP | 201,779 9.900% | 5,731 (+2.92%) | Filing |